Summary
IDEXX Laboratories, Inc. reported strong financial performance for the first quarter of 2019, with total revenue increasing by 7.1% year-over-year to $576.1 million. This growth was primarily driven by the Companion Animal Group (CAG) segment, which saw an 8.1% increase in revenue, notably from recurring revenue streams like consumables and reference laboratory services. The company also demonstrated improved profitability, with a 9.4% increase in gross profit and a 17.8% rise in income from operations. Despite a slight decrease in cash and cash equivalents, the company maintained a healthy liquidity position with significant availability under its credit facility. Key financial achievements include an 11.9% organic growth in CAG Diagnostics recurring revenue and a solid gross profit margin of 57.6%. The company successfully navigated the adoption of new accounting standards for leases (ASC 842) with minimal disruption. Management expressed confidence in the company's ability to fund its operations and growth initiatives, supported by ongoing cash generation and available credit lines.
Financial Highlights
51 data points| Revenue | $576.06M |
| Cost of Revenue | $244.46M |
| Gross Profit | $331.60M |
| R&D Expenses | $31.51M |
| Operating Income | $133.14M |
| Interest Expense | $8.39M |
| Net Income | $102.71M |
| EPS (Basic) | $1.19 |
| EPS (Diluted) | $1.17 |
| Shares Outstanding (Basic) | 86.20M |
| Shares Outstanding (Diluted) | 87.55M |
Key Highlights
- 1Total revenue increased by 7.1% to $576.1 million for the three months ended March 31, 2019, compared to the prior year.
- 2Income from operations grew by 17.8% to $133.1 million.
- 3The Companion Animal Group (CAG) segment, the largest contributor, saw revenue increase by 8.1% to $508.9 million.
- 4Gross profit margin improved to 57.6% from 56.4% in the prior year period.
- 5Operating expenses increased by 4.4%, outpacing revenue growth, but the company maintained strong operating leverage with a higher operating income percentage.
- 6The company successfully adopted the new Leases standard (ASC 842) as of January 1, 2019, with minor impacts on the balance sheet.
- 7Cash and cash equivalents decreased by $7.2 million, ending the quarter at $116.6 million, but the company maintained substantial liquidity with $501.7 million available under its credit facility.